BEY1107
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BEY1107, covering 2025-03-10 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) [Phase 1]